CollPlant Biotechnologies Ltd APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition
CollPlant Biotechnologies Ltd (CLGN) reported APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition of $1.00 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-26.
Financial Statements › Shareholders' Equity
us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition · last filed 2026-03-26
- CollPlant Biotechnologies Ltd apic, share-based payment arrangement, option, increase for cost recognition for the quarter ending 2025-06-30 was $353.00K, a 28.25% decline year-over-year.
- CollPlant Biotechnologies Ltd apic, share-based payment arrangement, option, increase for cost recognition for the quarter ending 2024-06-30 was $492.00K, a 65.10% increase year-over-year.
- CollPlant Biotechnologies Ltd apic, share-based payment arrangement, option, increase for cost recognition for the quarter ending 2023-06-30 was $298.00K.
| Period end | APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition 3 month | APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition 6 month | APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition 12 month |
|---|---|---|---|
| 2025-12-31 | $1.00M 20-F · filed 2026-03-26 | ||
| 2025-06-30 | $353.00K 6-K · filed 2025-08-20 | $737.00K 6-K · filed 2025-08-20 | |
| 2024-12-31 | $1.73M 20-F · filed 2026-03-26 | ||
| 2024-06-30 | $492.00K 6-K · filed 2025-08-20 | $785.00K 6-K · filed 2025-08-20 | |
| 2023-12-31 | $1.97M 20-F · filed 2026-03-26 | ||
| 2023-06-30 | $298.00K 6-K · filed 2024-08-20 | $819.00K 6-K · filed 2024-08-20 | |
| 2022-12-31 | $2.21M 20-F · filed 2025-03-26 | ||
| 2021-12-31 | $1.60M 20-F · filed 2024-04-04 |